Yoko Oei

4.7k total citations · 2 hit papers
17 papers, 3.6k citations indexed

About

Yoko Oei is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yoko Oei has authored 17 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Yoko Oei's work include bioluminescence and chemiluminescence research (3 papers), Immune cells in cancer (3 papers) and Bone health and treatments (2 papers). Yoko Oei is often cited by papers focused on bioluminescence and chemiluminescence research (3 papers), Immune cells in cancer (3 papers) and Bone health and treatments (2 papers). Yoko Oei collaborates with scholars based in United States, Switzerland and Germany. Yoko Oei's co-authors include Dylan Daniel, James Sutton, Lisa Sevenich, Daniela F. Quail, Alicia Pedraza, Marsha L. Quick, Robert L. Bowman, Johanna A. Joyce, Leila Akkari and Cameron Brennan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Yoko Oei

17 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

2013 1.8k citations Stephanie M. Pyonteck, Leila Akkari et al. Nature Medicine profile →
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines

2022 310 citations Siri Tähtinen, Ann-Jay Tong et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoko Oei United States	12	1.9k	1.4k	1.1k	541	379	17	3.6k
Oakley C. Olson United States	18	2.3k 1.2×	1.3k 1.0×	1.5k 1.4×	538 1.0×	396 1.0×	23	4.2k
Marsha L. Quick United States	12	1.9k 1.0×	763 0.6×	975 0.9×	636 1.2×	474 1.3×	15	2.9k
Dylan Daniel United States	15	3.0k 1.6×	1.2k 0.9×	1.6k 1.5×	495 0.9×	393 1.0×	23	4.5k
Lisa Sevenich Germany	20	2.1k 1.1×	1.2k 0.9×	1.4k 1.3×	805 1.5×	677 1.8×	31	3.9k
Wendy W. Pang United States	13	2.4k 1.2×	1.4k 1.0×	1.0k 1.0×	380 0.7×	99 0.3×	41	4.2k
Florian Klemm Germany	24	1.5k 0.8×	1.6k 1.2×	1.3k 1.2×	754 1.4×	462 1.2×	31	3.7k
Anna Kiialainen Switzerland	19	1.2k 0.6×	988 0.7×	1.0k 1.0×	203 0.4×	198 0.5×	35	2.9k
Laura Strauss United States	29	3.2k 1.6×	1.1k 0.8×	2.0k 1.8×	202 0.4×	114 0.3×	46	4.5k
Jun Wei United States	29	2.1k 1.1×	1.4k 1.0×	1.8k 1.6×	1.4k 2.5×	517 1.4×	57	4.2k
Magnus Essand Sweden	34	1.4k 0.7×	1.6k 1.2×	1.9k 1.7×	251 0.5×	160 0.4×	124	4.1k

Countries citing papers authored by Yoko Oei

Since Specialization

Citations

This map shows the geographic impact of Yoko Oei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Oei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Oei more than expected).

Fields of papers citing papers by Yoko Oei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Oei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Oei. The network helps show where Yoko Oei may publish in the future.

Co-authorship network of co-authors of Yoko Oei

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Oei. A scholar is included among the top collaborators of Yoko Oei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Oei. Yoko Oei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tähtinen, Siri, Ann-Jay Tong, Patricia Himmels, et al.. (2022). IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nature Immunology. 23(4). 532–542. 310 indexed citations breakdown →

Keerthivasan, Shilpa, Yasin Şenbabaoğlu, Nadia Martinez-Martín, et al.. (2021). Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1. Immunity. 54(7). 1511–1526.e8. 46 indexed citations

Vormehr, Mathias, Sophie M. Lehar, Lena M. Kranz, et al.. (2020). Dexamethasone premedication suppresses vaccine-induced immune responses against cancer. OncoImmunology. 9(1). 1758004–1758004. 17 indexed citations

Strachan, Debbie, Brian Ruffell, Yoko Oei, et al.. (2013). CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8⁺T cells. OncoImmunology. 2(12). e26968–e26968. 314 indexed citations

Pyonteck, Stephanie M., Leila Akkari, Alberto J. Schuhmacher, et al.. (2013). CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nature Medicine. 19(10). 1264–1272. 1799 indexed citations breakdown →

Wiesmann, Marion, Dylan Daniel, Nancy Pryer, et al.. (2010). Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone. Cancer Research. 70(8_Supplement). 3629–3629. 9 indexed citations

Pryer, Nancy, Victoria Sung, Ursula Jeffry, et al.. (2009). Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis. Cancer Research. 69. 1 indexed citations

Xin, Xiaohua, Tinya J. Abrams, Paul W. Hollenbach, et al.. (2006). CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice. Clinical Cancer Research. 12(16). 4908–4915. 53 indexed citations

Zhu, Qing, Yoko Oei, Dirk B. Mendel, et al.. (2006). Novel Robust Hepatitis C Virus Mouse Efficacy Model. Antimicrobial Agents and Chemotherapy. 50(10). 3260–3268. 26 indexed citations

10.

Jenkins, Darlene E., et al.. (2005). Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivodetection of mammary tumors and multiple metastases in immune deficient mice. Breast Cancer Research. 7(4). R444–54. 170 indexed citations

11.

Xin, Xiaohua, Yan Tang, Yoko Oei, et al.. (2005). CHIR-258 Efficacy in a Newly Developed Preclinical Bone Marrow Model of t(4;14) Multiple Myeloma.. Blood. 106(11). 3449–3449. 1 indexed citations

12.

Menezes, Daniel E. Lopes de, Evelyn N. Garrett, Sharianne G. Louie, et al.. (2005). CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia. Clinical Cancer Research. 11(14). 5281–5291. 95 indexed citations

13.

Scatena, Caroline D., Yoko Oei, Shang‐Fan Yu, et al.. (2004). Imaging of bioluminescent LNCaP‐luc‐M6 Tumors: A new animal model for the study of metastatic human prostate cancer. The Prostate. 59(3). 292–303. 58 indexed citations

14.

Jenkins, Darlene E., et al.. (2003). Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clinical & Experimental Metastasis. 20(8). 733–744. 243 indexed citations

15.

Yang, Jiwei, Edwin Chang, Athena M. Cherry, et al.. (1999). Human Endothelial Cell Life Extension by Telomerase Expression. Journal of Biological Chemistry. 274(37). 26141–26148. 421 indexed citations

16.

Yoon, Seung Soo, et al.. (1996). An Antibody-Catalyzed [2,3]-Elimination Reaction. Journal of the American Chemical Society. 118(46). 11686–11687. 8 indexed citations

17.

Fan, Erkang, et al.. (1996). Antibodies with Thiol-S-Transferase Activity. Journal of the American Chemical Society. 118(23). 5474–5475. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact